ABSTRACT:
In the current study, Seventy menopausal women have CHD were admitted to the coronary care unit of AL-Sader teaching hospital in AL-najaf AL-Ashraf during the period from January to April/2016 for the ages were ranging from 40 to 69 years old. The samples were divided into three groups (SA 25, UA 22, AMI 23), while the healthy group was composed of 20. The current study indicated a significant decrease (P<0.05)in serum E2 and GS concentration of CHD compared with healthy group. The serum of E2 and GS concentrations showed a significantly decrease (p<0.05) in AMI compare with UA and SA groups of CHD. The result indicated a positive correlation between E2 and GS. Conclusion: The present study concluded that E2 and GS levels were markers for detection and diagnosis of Coronary heart disease in menopausal women.
Cite this article:
Wijdan Rajh Hamza Al-Kraity, Arshad Noori Ghani Al-Dujaili. Assessment of Gelsolin Level in women with heart disease after menopause. Research J. Pharm. and Tech. 2017; 10(6): 1657-1660. doi: 10.5958/0974-360X.2017.00292.X
Cite(Electronic):
Wijdan Rajh Hamza Al-Kraity, Arshad Noori Ghani Al-Dujaili. Assessment of Gelsolin Level in women with heart disease after menopause. Research J. Pharm. and Tech. 2017; 10(6): 1657-1660. doi: 10.5958/0974-360X.2017.00292.X Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2017-10-6-15